Sotera Health Company
SHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -7.84 | -0.76 | 0.03 | -0.14 |
| FCF Yield | 1.17% | -7.66% | 4.10% | 2.73% |
| EV / EBITDA | 13.44 | 16.63 | -227.99 | 20.70 |
| Quality | ||||
| ROIC | 4.00% | 4.59% | 9.42% | 6.46% |
| Gross Margin | 54.73% | 55.00% | 55.50% | 55.68% |
| Cash Conversion Ratio | 5.05 | -2.88 | -1.19 | 2.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.12% | 4.05% | 7.05% | 6.17% |
| Free Cash Flow Growth | 112.43% | -479.47% | -46.72% | 167.42% |
| Safety | ||||
| Net Debt / EBITDA | 4.69 | 4.99 | -94.00 | 4.29 |
| Interest Coverage | 1.81 | 1.94 | 3.10 | 3.46 |
| Efficiency | ||||
| Inventory Turnover | 10.13 | 9.77 | 12.03 | 7.60 |
| Cash Conversion Cycle | 50.64 | 43.49 | 26.40 | 36.10 |